6.
Song J, Chaudhry F, Mayo-Smith W
. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008; 190(5):1163-8.
DOI: 10.2214/AJR.07.2799.
View
7.
Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J
. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023; 189(1):G1-G42.
DOI: 10.1093/ejendo/lvad066.
View
8.
Reincke M, Fleseriu M
. Cushing Syndrome: A Review. JAMA. 2023; 330(2):170-181.
DOI: 10.1001/jama.2023.11305.
View
9.
Ceccato F, Barbot M, Scaroni C, Boscaro M
. Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J Endocrinol Invest. 2021; 44(12):2749-2763.
PMC: 8572215.
DOI: 10.1007/s40618-021-01615-3.
View
10.
Kirsch M, Hsu K, Lee M, Pickhardt P, Kim D, Sippel R
. Hormonal Evaluation of Incidental Adrenal Masses: The Exception, Not the Rule. World J Surg. 2020; 44(11):3778-3785.
DOI: 10.1007/s00268-020-05679-9.
View
11.
Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E
. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014; 2(5):396-405.
DOI: 10.1016/S2213-8587(13)70211-0.
View
12.
Korobkin M, Brodeur F, Yutzy G, Francis I, Quint L, Dunnick N
. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996; 166(3):531-6.
DOI: 10.2214/ajr.166.3.8623622.
View
13.
He K, Zhang Z, Wang Z, Wang Y, Wang Y, Zhang H
. A Clinical-Radiomic Nomogram Based on Unenhanced Computed Tomography for Predicting the Risk of Aldosterone-Producing Adenoma. Front Oncol. 2021; 11:634879.
PMC: 8300014.
DOI: 10.3389/fonc.2021.634879.
View
14.
Ceccato F, Tizianel I, Voltan G, Maggetto G, Merante Boschin I, Quaia E
. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study. Front Endocrinol (Lausanne). 2021; 12:794197.
PMC: 8678594.
DOI: 10.3389/fendo.2021.794197.
View
15.
Sikic Z
. Rules of thumb for positive and negative test results. J Eval Clin Pract. 2020; 27(1):158-159.
DOI: 10.1111/jep.13406.
View
16.
Veiga-Canuto D, Cerda-Alberich L, Sanguesa Nebot C, de Las Heras B, Potschger U, Gabelloni M
. Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images. Cancers (Basel). 2022; 14(15).
PMC: 9367307.
DOI: 10.3390/cancers14153648.
View
17.
Nioche C, Orlhac F, Boughdad S, Reuze S, Goya-Outi J, Robert C
. LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity. Cancer Res. 2018; 78(16):4786-4789.
DOI: 10.1158/0008-5472.CAN-18-0125.
View
18.
Qi S, Zuo Y, Chang R, Huang K, Liu J, Zhang Z
. Using CT radiomic features based on machine learning models to subtype adrenal adenoma. BMC Cancer. 2023; 23(1):111.
PMC: 9890822.
DOI: 10.1186/s12885-023-10562-6.
View
19.
Kawashima A, Sandler C, Fishman E, Charnsangavej C, Yasumori K, Honda H
. Spectrum of CT findings in nonmalignant disease of the adrenal gland. Radiographics. 1998; 18(2):393-412.
DOI: 10.1148/radiographics.18.2.9536486.
View